U.S. federal trademark · Serial No. 86689197
Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.